Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7347 p512
30 April 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Calcium and vitamin D3 supplements do not prevent fractures

Supplementation with calcium and vitamin D3, either alone or in combination, is not effective in the prevention of fractures in elderly people, according to two new UK studies.

The first study involved 5,292 people aged 70 years or older who had had a low-trauma osteoporotic fracture in the previous 10 years. Participants received a daily supplement of either 800 IU vitamin D3, 1,000mg calcium, a combination of these two, or placebo. Follow up was for between 24 and 62 months.

A total of 698 participants had a new low-trauma fracture but no difference was observed between the treatment or placebo groups in the incidence of fractures. The researchers conclude that policies for secondary prevention of fractures should consider other strategies. They note that the value of supplements for primary prevention or for those in care homes was not addressed in their study (published online on 28 April in The Lancet at www.thelancet.com).

The second study involved 3,314 women in primary care aged 70 years or older with one or more risk factors for hip fracture. Participants received a daily supplement of 1,000mg calcium and 800 IU vitamin D3 along with a leaflet on dietary calacium intake and falls prevention, or a leaflet alone.

After a median follow up of 25 months, 149 fractures were reported (lower than anticipated) but no difference in rate of all fractures was found between the two groups. The researchers conclude that they found no evidence that supplementation with calcium and vitamin D3 affects fracture rates in this population (BMJ 2005;330:1003).

Back to Top


©The Pharmaceutical Journal